Altus Wealth Group’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,543
Closed -$416K 144
2022
Q3
$416K Sell
5,543
-1,425
-20% -$71.3K 0.41% 64
2022
Q2
$416K Sell
6,968
-548
-7% -$28.1K 0.41% 64
2022
Q1
$425K Buy
7,516
+129
+2% +$6.74K 0.35% 63
2021
Q4
$384K Buy
7,387
+419
+6% +$21.6K 0.32% 72
2021
Q3
$416K Buy
6,968
+606
+10% +$38.1K 0.41% 64
2021
Q2
$395K Buy
6,362
+42
+0.7% +$2.8K 0.39% 61
2021
Q1
$430K Buy
6,320
+735
+13% +$47.9K 0.43% 58
2020
Q4
$367K Buy
+5,585
New +$329K 0.35% 57

Other funds holding EHC

Altus Wealth Group's EHC Position: Q4 2022 in Review

Altus Wealth Group sold out of Encompass Health (EHC) in Q4 2022, closing a stake of 5,543 shares — an estimated $416K sold.

Altus Wealth Group first reported a position in EHC in Q4 2020 and held it in 8 quarters. The position peaked at $430K in Q1 2021. 374 funds tracked by Wall St. Rank hold EHC as of Q4 2022.

  • Altus Wealth Group reported no remaining Encompass Health position as of Q4 2022 after selling out during the quarter.
  • Altus Wealth Group sold 5,543 Encompass Health shares in Q4 2022, an estimated $416K.
  • Altus Wealth Group first reported a position in Encompass Health in Q4 2020 and held it in 8 quarters.
  • Altus Wealth Group's Encompass Health position peaked at $430K in Q1 2021.
  • 374 funds tracked by Wall St. Rank held Encompass Health as of Q4 2022.

Based on Altus Wealth Group's 13F filing for Q4 2022, filed 18 Jan 2023.